Hui Ma

2.9k total citations
126 papers, 2.1k citations indexed

About

Hui Ma is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hui Ma has authored 126 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 30 papers in Hepatology and 29 papers in Molecular Biology. Recurrent topics in Hui Ma's work include Liver Disease Diagnosis and Treatment (35 papers), Hepatitis B Virus Studies (23 papers) and Hepatitis C virus research (20 papers). Hui Ma is often cited by papers focused on Liver Disease Diagnosis and Treatment (35 papers), Hepatitis B Virus Studies (23 papers) and Hepatitis C virus research (20 papers). Hui Ma collaborates with scholars based in China, United States and Netherlands. Hui Ma's co-authors include Xin Gao, Huandong Lin, Mingfeng Xia, Yu Hu, Jian Gao, Qiqige Aleteng, Xiaoming Li, Lai Wei, Wanyuan He and Baishen Pan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hui Ma

118 papers receiving 2.1k citations

Peers

Hui Ma
Comparison fields: 5 of 124
  • Epidemiology 682
  • Molecular Biology 467
  • Hepatology 394
  • Endocrinology, Diabetes and Metabolism 325
  • Physiology 275
Replace Alberto Piperno with:
Alberto Piperno Italy
Dewei Ye China
Wei Liao China
Antonios Chatzigeorgiou Greece
Xu Li China
Meng Ren China
Ji Sun Nam South Korea
Shinae Kang South Korea
Alberto Piperno Italy View profile →
Citations per field, relative to Hui Ma
Hui Ma · 1×
Citations per year, relative to Hui Ma
Hui Ma · 1×

Countries citing papers authored by Hui Ma

Since Specialization
Citations

This map shows the geographic impact of Hui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ma more than expected).

Fields of papers citing papers by Hui Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ma. The network helps show where Hui Ma may publish in the future.

Co-authorship network of co-authors of Hui Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Ma. A scholar is included among the top collaborators of Hui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Ma. Hui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 9
2 4
3 4
4 2
5 3
6 6
7 6
8 1
9 0
10 1
11
Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
2
12 35
13 14
14 164
15 6
16 11
17 7
18 20
19 21
20
Effect of ginsenoside Rg1 and Rh1 on the anti-tumor activity of endritic cells
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026